Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Blend Broad Market
  • Asset Class: Equity
  • Geographic Focus: U.S.

Hartford Capital Appreciation HLS Fund

+ Add to Watchlist

HIBCX:US

57.59 USD 0.49 0.84%

As of 09:29:30 ET on 05/29/2015.

Snapshot for Hartford Capital Appreciation HLS Fund (HIBCX)

Year To Date: +6.25% 3-Month: +2.27% 3-Year: +21.33% 52-Week Range: 49.44 - 58.38
1-Month: +1.44% 1-Year: +10.48% 5-Year: +14.53% Beta vs SPX: 1.03

Mutual Fund Chart for HIBCX

No chart data available.
  • HIBCX:US 57.59
  • 1M
  • 1Y
Interactive HIBCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for HIBCX

Hartford Capital Appreciation HLS Fund is an open-end fund incorporated in the USA. The Fund's objective is growth of capital. The Fund invests primarily in stocks selected on the basis of potential for capital appreciation. The Fund normally invests at least 65% of its total assets in common stocks of small, medium and large companies.

Inception Date: 04-02-1984 Telephone: 1-800-862-6668
Managers: SAUL J PANNELL / PETER I HIGGINS
Web Site: www.invest.hartfordlife.com

Fundamentals for HIBCX

NAV (on 2015-05-29) 57.59
Assets (M) (on 2015-05-29) 7,214.73
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for HIBCX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-12-22) 0.29
Dividend Yield (ttm) 15.79

Fees & Expenses for HIBCX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.63
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 0.91

Top Fund Holdings for HIBCX

Filing Date: 03/31/2015
Name Position Value % of Total
Bristol-Myers Squibb Co 3,579,113 230,852,789 3.206%
Actavis plc 504,339 150,101,373 2.085%
Apple Inc 1,095,172 136,272,252 1.893%
Merck & Co Inc 2,337,736 134,373,065 1.866%
JPMorgan Chase & Co 1,744,930 105,707,859 1.468%
Google Inc 182,106 99,520,636 1.382%
Microsoft Corp 2,355,831 95,776,309 1.330%
Activision Blizzard Inc 4,031,590 91,617,883 1.272%
Intel Corp 2,885,253 90,221,861 1.253%
Facebook Inc 1,044,407 85,865,922 1.193%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil